Multnomah, Oregon (OR) Commercial Medical Research Companies

Featured companies
Biogift Anatomical Inc
17819 Ne Riverside Parkway # C
Portland OR 97230
(503) 489-2126
Capatheter Systems
15060 Nw Central Drive
Portland OR 97229
(503) 970-9862
Clinical Research Services Inc
231 Nw Seblar Drive
Portland OR 97210
(941) 223-5033
Not satisfied? Select a reasonRate this pageSend feedback

Or try our search form or quick navigation by category and location

Fiberlite Composites Inc
7010 Se 32nd Avenue
Portland OR 97202
(541) 344-2882
Gamma Therapeutics
2611 Sw 3rd Avenue
Portland OR 97201
(503) 222-2306

Gamma Therapeutics is a privately held company in Portland, OR and is a Unknown business.
Hepatitis C Outreach Project
7316 North Mobile Avenue
Portland OR 97217
Occi Inc
2232 Nw Pettygrove St.
Portland OR 97214
Oregon Clinical Research
13219 Se Evening Star Drive
Portland OR 97086
Senaptec LLC
2331 Nw Jessamine Way
Portland OR 97229
(503) 746-7323
Testicular Cancer Commons
7870 Se 13th Avenue Apartment 401
Portland OR 97202
(503) 841-5433
University Immunogenetics
2611 Sw 3rd Avenue
Portland OR 97201
(503) 494-8394
Whereorg has 11 results under Commercial Medical Research Companies in Multnomah.

Narrow down the browsing criteria below to see more companies.

Select a location for category Commercial Medical Research

All states Oregon Multnomah


Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020